Search - tctmd.com

Displaying 81 - 100 of 246

Sort: Relevancy | Date

News Industry News

Boston Scientific Responds to the FDA’s Guidance on Use of Peripheral Paclitaxel Devices for Treatment of PAD

August 07, 2019

News Daily News

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Michael O'Riordan

July 10, 2019

News Daily News

Hybrid Revascularization for Multivessel CAD Rarely Used in the US

Todd Neale

July 04, 2019

News Conference News EuroPCR 2019

Mortality Appears to Rise When SYNTAX II Score’s Advice for CABG Is Ignored: EXCEL Analysis

L.A. McKeown

June 07, 2019

News Conference News EuroPCR 2019

New Clarity on Patients at High Risk for Bleeding After PCI

Michael O'Riordan

May 28, 2019

News Conference News EuroPCR 2019

Drug-Coated Balloons in STEMI ‘Safe and Feasible’ in Specific Circumstances: REVELATION

L.A. McKeown

May 22, 2019

Time and Money: PCI Public Reporting Requirements Takes Their Toll

News Conference News ACC 2019

Time and Money: PCI Public Reporting Requirements Take Their Toll

Michael O'Riordan

March 26, 2019

News Conference News ACC 2019

SAFARI Surprise: No Survival or Bleeding Advantage With Radial Over Femoral Access in STEMI

Michael O'Riordan

March 18, 2019

News Conference News CRT 2019

CABG vs PCI in Left Main Disease: The Debate Continues

Yael L. Maxwell

March 12, 2019

News Daily News

The Case for Collateralization: CABG’s Mechanism for Survival in Stable CAD Underappreciated by Patients

L.A. McKeown

February 26, 2019

News Daily News

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

Todd Neale

January 15, 2019

News Daily News

Unprotected Left Main PCI? US Interventionalists Aren’t Biting (Yet)

Michael O'Riordan

January 08, 2019

Even With PSP, Bioresorbable Scaffold Falls Short in ABSORB-COMPARE and ABSORB IV Trials

News Conference News TCT 2018

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

Michael O'Riordan

September 25, 2018

News Conference News TCT 2018

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

Michael O'Riordan

September 25, 2018

News Conference News TCT 2018

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

Michael O'Riordan

September 21, 2018

News Daily News

PCI in Nonagenarians Rising as Focus Shifts to Frailty Over Age

Yael L. Maxwell

September 18, 2018

News Conference News ESC 2018

Too Little, Too Late? Absorb BVS Shows Promising Results in STEMI Patients

Michael O'Riordan

August 28, 2018

News Daily News

New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients

Michael O'Riordan

August 13, 2018

News Daily News

CKD Patients With Left Main Disease See Similar Outcomes at 3 Years After PCI vs CABG: EXCEL

Caitlin E. Cox

August 09, 2018

News Daily News

Less Stroke With PCI at 5 Years, but CABG Risks Front-loaded in First 30 Days

Michael O'Riordan

July 19, 2018

Advertisement

Boston Scientific Responds to the FDA’s Guidance on Use of Peripheral Paclitaxel Devices for Treatment of PAD

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Hybrid Revascularization for Multivessel CAD Rarely Used in the US

Mortality Appears to Rise When SYNTAX II Score’s Advice for CABG Is Ignored: EXCEL Analysis

New Clarity on Patients at High Risk for Bleeding After PCI

Drug-Coated Balloons in STEMI ‘Safe and Feasible’ in Specific Circumstances: REVELATION

Time and Money: PCI Public Reporting Requirements Take Their Toll

SAFARI Surprise: No Survival or Bleeding Advantage With Radial Over Femoral Access in STEMI

CABG vs PCI in Left Main Disease: The Debate Continues

The Case for Collateralization: CABG’s Mechanism for Survival in Stable CAD Underappreciated by Patients

Slight Advantage for DES Over DCB for In-Stent Restenosis: Updated Meta-analysis

Unprotected Left Main PCI? US Interventionalists Aren’t Biting (Yet)

Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

EXCEL Deep Dive: Repeat Revascularization, Medical Therapy, and Anemia All Impact Patient Prognosis

PCI in Nonagenarians Rising as Focus Shifts to Frailty Over Age

Too Little, Too Late? Absorb BVS Shows Promising Results in STEMI Patients

New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients

CKD Patients With Left Main Disease See Similar Outcomes at 3 Years After PCI vs CABG: EXCEL

Less Stroke With PCI at 5 Years, but CABG Risks Front-loaded in First 30 Days

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content